Friday, March 31, 2017 6:22:31 AM
Sucampo reaffirmed its guidance for the full year 2017. The company expects total revenue in the range of $220.0 million to $230.0 million. The Zacks Consensus Estimate for 2017 is $227.28 million.
The company expects adjusted net income in the range of $80.0 million to $90.0 million, and adjusted earnings in the range of $1.35 to $1.50
The company forecasts adjusted EBITDA of $145.0 million to $155.0 million. Adjusted EBITDA guidance excludes stock option related costs of $6.0 million.
http://finance.yahoo.com/news/sucampo-scmp-beats-q4-earnings-155303108.html
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM